Skip to content
To address the increasing problem of Lyme disease on Nantucket, MIT scientists propose releasing hundreds of thousands of genetically altered mice on the island, […]
Gene-edited mice with Lyme disease immunity could help humans Read More »
The House Energy & Commerce Committee unveiled on Wednesday “a bipartisan comprehensive legislative package to reauthorize the Food and Drug Administration (FDA) user fee
House unveils package to reauthorize FDA user fee agreements Read More »
The opioid epidemic has hit the United States hard in the last 25 years, killing more than 70,000 in 2019 alone, according to the
FDA draft guidance on non-opioid analgesics ‘inadequate’ Read More »
Envionmental, Social and corporate Governance (ESG) investors should take into account all the good that biotechnolgy is doing, BIO President and CEO Dr. Michelle
BIO’s CEO in Forbes: Biotech offers value for ESG investors Read More »
In her latest I am BIO Podcast, BIO President and CEO Dr. Michelle McMurry-Heath speaks with three guests who are fighting to bend the
I am BIO Podcast: Hope for Alzheimer’s Read More »
Certain serious psychiatric or gastrointestinal conditions require neuroleptic drugs, which are designed to block dopamine receptors in the brain and central nervous system, but
Awareness of tardive dyskinesia is the best defense Read More »
A man in Colorado tested positive for an H5 bird flu virus, marking the first recorded human infection in the United States of the
First U.S. case of human infected with bird flu reported in Colorado Read More »
In the United States, over 500 people lose a limb daily, the Amputee Coalition says, adding that the number of people living with limb
National Limb Loss and Limb Difference Awareness Month highlights risks and challenges Read More »
Today on the House floor, U.S. Rep. Nanette Diaz Barragán (D-CA) spoke out against the recent Centers for Medicare and Medicaid Services (CMS) decision
Rep. Barragán: CMS Alzheimer’s drug decision is ‘a mistake’ Read More »
The Lyme disease vaccine candidate developed by Pfizer and Valneva was “found to be more immunogenic” in pediatric patients than in adults in a
Pfizer-Valneva Lyme vaccine shows promising results in children Read More »
